The Dopamine Hypothesis of Schizophrenia: An Historical and ...

Kendler and Schaffner / Dopamine Hypothesis of Schizophrenia ■ 63
choses. Neuroscience Research Program Bulletin
10, no. 4:430–45.
Snyder, S. H., S. P. Banerjee, H. I. Yamamura, and D.
Greenberg. 1974. Drugs, neurotransmitters, and
schizophrenia. Science 184, no. 4143:1243–53.
Sokoloff, P., B. Giros, M. P. Martres, M. L. Bouthenet,
et al. 1990. Molecular cloning and characterization
of a novel dopamine receptor (D3) as a target for
neuroleptics. Nature 347, no. 6289:146–51.
Sourkes, T. L. 1973. On the origin of homovanillic acid
(HVA) in the cerebrospinal fluid. Journal of Neural
Transmission 34:153–7.
Steinberg, J. L., D. L. Garver, F. G. Moeller, P. J. Orsulak,
et al. 1993. Serum homovanillic-acid levels in
schizophrenic-patients and normal controls. Biological
Psychiatry 33, no. 6A:A99.
Sullivan, P. F., K. S. Kendler, and M. C. Neale. 2003.
Schizophrenia as a complex trait: Evidence from a
meta-analysis of twin studies. Archives of General
Psychiatry 60, no. 12:1187–92.
Sumiyoshi, T., O. Saitoh, T. Yotsutsuji, H. Itoh, et al.
1999. Differential effects of mental stress on plasma
homovanillic acid in schizophrenia and normal controls.
Neuropsychopharmacology 20, no. 4:365–9.
Sunahara, R. K., H. C. Guan, B. F. O’Dowd, P. Seeman,
et al. 1991. Cloning of the gene for a human dopamine
D5 receptor with higher affinity for dopamine
than D1. Nature 350, no. 6319:614–9.
Talkowski, M. E., M. Bamne, H. Mansour, and V. L.
Nimgaonkar. 2007. Dopamine genes and schizophrenia:
Case closed or evidence pending? Schizophrenia
Bulletin 33, no. 5:1071–81.
Tamminga, C. A., M. D. Gotts, G. K. Thakar, L. D.
Alphs, et al. 1986. Dopamine agonist treatment
of schizophrenia with N-propylnorapomorphine.
Archives of General Psychiatry 43, no. 4:398–402.
Thagard, P. 2000. How scientists explain disease. Princeton,
NJ: Princeton University Press.
Tuckwell, H. C., and J. A. Kosiol. 1993. A meta-analysis
of homovanillic acid concentrations in schizophrenia.
International Journal of Neuroscience 73:109–14.
Tune, L. E., D. F. Wong, G. Pearlson, M. Strauss, et
al. 1993. Dopamine D2 receptor density estimates
in schizophrenia: A positron emission tomography
study with 11C-N-methylspiperone. Psychiatry
Research 49, no. 3:219–37.
Valenstein, E. S. 1998. Blaming the brain: The truth
about drugs and mental health. New York: The
Free Press.
van Rossum, J. M. 1967. The significance of dopaminereceptor
blockade for the action of neuroleptic
drugs. Neuropsychopharmacology excerpta Medica
Foundation, Amsterdam, 1967:321–9.
Van Tol, H. H., J. R. Bunzow, H. C. Guan, R. K. Sunahara,
et al. 1991. Cloning of the gene for a human
dopamine D4 receptor with high affinity for the antipsychotic
clozapine. Nature 350, no. 6319:610–4.
Williams, H. J., B. Glaser, N. M. Williams, N. Norton,
et al. 2005. No association between schizophrenia
and polymorphisms in COMT in two large samples.
American Journal of Psychiatry 162, no. 9:1736–8.
Willner, P. 1997. The dopamine hypothesis of schizophrenia:
current status, future prospects. International
Clinical Psychopharmacology 12, no. 6:297–308.
Wong, D. F., G. D. Pearlson, L. E. Tune, L. T. Young,
et al. 1997. Quantification of neuroreceptors in the
living human brain. 4. Effect of aging and elevations
of D-2-like receptors in schizophrenia and bipolar
illness. Journal of Cerebral Blood Flow and Metabolism
17, no. 3:331–42.
Zhang, B., Y. Jia, Y. Yuan, X. Yu, et al. 2004. No association
between polymorphisms in the DDC gene
and paranoid schizophrenia in a northern Chinese
population. Psychiatric Genetics 14, no. 3:161–3.
Zhang, Z. J., M. Peet, C. N. Ranchand, S. Shah, et al.
2001. Plasma homovanillic acid in untreated schizophrenia—Relationship
with symptomatology and
sex. Journal of Psychiatric Research 35, no. 1:23–8.